The difficulties also occur in cryptic gene fusions, for example, NUP98-NSD1, CBFA2T3–GLIS2, and MNX1–ETV6, which predict poor outcomes in pediatric and young adult AML (Grimwade et al., 2016). The gene discussed is CBFA2T3; the disease is acute myeloid leukemia.